Foundry Partners’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-39,862
| Closed | -$737K | – | 391 |
|
|
2018
Q3 | $737K | Sell |
39,862
-62
| -0.2% | -$1.15K | 0.03% | 338 |
|
|
2018
Q2 | $913K | Sell |
39,924
-2,578
| -6% | -$59K | 0.04% | 323 |
|
|
2018
Q1 | $1.21M | Sell |
42,502
-98
| -0.2% | -$2.79K | 0.05% | 315 |
|
|
2017
Q4 | $899K | Sell |
42,600
-33,675
| -44% | -$711K | 0.04% | 320 |
|
|
2017
Q3 | $1.39M | Sell |
76,275
-223
| -0.3% | -$4.05K | 0.06% | 313 |
|
|
2017
Q2 | $1.19M | Buy |
+76,498
| New | +$1.19M | 0.05% | 325 |
|